Low expression of SHP-2 is associated with less favorable prostate cancer outcomes

: Tassidis H, Brokken L B, Jirström K, Bjartell A, Ulmert D, Härkönen P, Gjörloff Wingren A

: 2013

: Tumor Biology

: 34

: 2

: 637

: 642

: 6

: 1010-4283

DOI: https://doi.org/10.1007/s13277-012-0590-1